Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review.

W Storms, MS Bowdish… - Allergy & Asthma …, 2012 - search.ebscohost.com
Controlled clinical trials have shown the recombinant humanized monoclonal anti-IgE
antibody omalizumab to improve asthma control and reduce symptom exacerbations in …
被引用次数：39 相关文章

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review.

W Storms, MS Bowdish, JR Farrar - Allergy and Asthma …, 2012 - europepmc.org
Controlled clinical trials have shown the recombinant humanized monoclonal anti-IgE
antibody omalizumab to improve asthma control and reduce symptom exacerbations in …

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review

W Storms, MS Bowdish… - Allergy and asthma …, 2012 - pubmed.ncbi.nlm.nih.gov
Controlled clinical trials have shown the recombinant humanized monoclonal anti-IgE
antibody omalizumab to improve asthma control and reduce symptom exacerbations in …

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review

W Storms, MS Bowdish… - Allergy and Asthma …, 2012 - ingentaconnect.com
Controlled clinical trials have shown the recombinant humanized monoclonal anti-IgE
antibody omalizumab to improve asthma control and reduce symptom exacerbations in …

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review

W Storms, MS Bowdish… - Allergy and Asthma …, 2012 - search.proquest.com
Controlled clinical trials have shown the recombinant humanized monoclonal anti-IgE
antibody omalizumab to improve asthma control and reduce symptom exacerbations in …

Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review.

W Storms, MS Bowdish… - Allergy & Asthma …, 2012 - search.ebscohost.com
Controlled clinical trials have shown the recombinant humanized monoclonal anti-IgE
antibody omalizumab to improve asthma control and reduce symptom exacerbations in …